Approval · Notice of Compliance 34005 · 2024
INDAYO: Notice of Compliance 34005
Issued September 12, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 34005
- Date
- September 12, 2024
- Company
- Mylan Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to Product Monograph (to align with CRP approved PM)
- Canadian reference product
- SEASONALE
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| INDAYO | Not yet assigned | — |
Medicinal ingredients
- ETHINYL ESTRADIOL 0.03 MG per TAB
- LEVONORGESTREL 0.15 MG per TAB